Recent Verdicts Against Wyeth Underscore Momentum in Favor of Plaintiffs Who Claim to Have Developed Breast Cancer as the Result of Hormone Therapy
KPA Moves Forward in Complex Litigation on Behalf of Women with Breast Cancer Linked to Premarin and Prempro
Two multi-million dollar verdicts in Philadelphia last week against pharmaceutical company Wyeth, a division of Pfizer, reinforce that juries are consistently finding the company responsible for breast cancer in women who took its Premarin and Prempro hormone replacement therapy (HRT) drugs.
And just last month, a ruling from the 8th Circuit Court of Appeals confirmed that Wyeth did wrong, and that juries should be permitted to hear this evidence and determine whether the company should be punished.
In the verdicts announced last week, juries awarded Donna Kendall of Decatur, Illinois $6.3 million in compensatory and $28 million in punitive damages, and Connie Barton of Peoria, Illinois $3.7 million in compensatory and $75 million in punitive damages.
Through an ongoing federal multi-district litigation mass tort action, Wyeth still faces lawsuits from more than 10,000 women nationwide who claim that the company’s drugs caused their breast cancer. Of the 12 verdicts announced to date, plaintiffs have been awarded money in 10 of the cases. Every jury that has been permitted to deliberate on punitive damages has returned substantial awards.
To date, winning plaintiffs have been awarded a total of more than $42 million in compensatory and $165 million in punitive damages. In addition, 13 women have settled their HRT claims with Wyeth or Pfizer outside of court.
Shawn Khorrami, founding partner of KPA, is a member of the Plaintiffs’ Steering Committee for the MDL litigation team, and his firm represents around 150 individuals pursuing cases against Wyeth.
A press release on the firm’s involvement with the litigation was released today. For more information on the Barton and Kendall verdicts watch the video below.
Synthetic Hormones, Pfizer-Wyeth Lose Big Court Case
A 112 million dollar punitive award indicates outrage at the "wanton and reckless” conduct by Wyeth for pushing a cancer causing pill. This is the tip of the iceberg, as another ten thousand cases are waiting for their day in court.
Seven years ago, the 2002 WHI study revealed that PremPro causes breast cancer, and millions of women shifted away from synthetic Prempro. The result of this flight from Prempro was a dramatic decline in breast cancer rates, and a shift to the safety and efficay of bioidentical hormones..
For More:
http://jeffreydach.com/2009/11/27/synthetic-hormones-pfizerwyeth-lose-big-court-case-by-jeffrey-dach-md.aspx